Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05252871
Other study ID # P21/IRB/065
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 9, 2021
Est. completion date June 6, 2022

Study information

Verified date July 2022
Source Western University of Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.


Description:

The purpose of the study is to evaluate the preference, adaptability, and visual performance of three progressive lens designs. The difference in these lens designs is a variation of zone sizes for intermediate and near vision. The clinical trial helps manufacturers and eye care practitioners to give detailed suggestions to patients. Study participants will be experienced progressive addition lens wearers, which will be recruited by advertisements, by email, and with direct person-to-person solicitation. The study will be conducted at the Eye Care Institute at the Patient Care Center Western University of Health Sciences, Pomona, CA, 91766. For each participant, the study is completed in around two months and requires three separate visits.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date June 6, 2022
Est. primary completion date June 6, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 45 Years to 70 Years
Eligibility Inclusion Criteria: - Age: 45 to 70 years old. - Visual Acuity: far & near monocular: cc = 20/20 (decimal cc = 1.0) - Normal binocular vision (at distance & near: no strabismus on cover testing, aligning prism of less than 2? horizontally or vertically, stereoacuity of 2' or better at distance and near). - Prescription is in the range: - Spherical power: less than +/-6.00 D - Cylindrical power: less than -2.75 D - Addition: 1.50 D - 2.50 D - Difference in power (spherical equivalent) between eyes: less than 2.00 D Exclusion Criteria: - Have never worn any progressive lens design. - First prescription for progressive lenses. - Prescription found during visit#1 varies from current prescription more than 0.50 D in any meridian. - Currently wearing single vision lenses with accommodative support. - Double vision or prismatic prescription in current glasses. - Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity. - Use of systemic or ocular medications that are likely to affect vision. - Balance problem/vertigo problem. - Concurrent participation in other vision-related research.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Subjects will be wearing three different PAL designs with different geometries of the optical progression.

Locations

Country Name City State
United States Western University of Health Sciences Pomona California

Sponsors (2)

Lead Sponsor Collaborator
Western University of Health Sciences Hoya Cooperation Vision Care

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the adaptation to progressive lens designs. Evaluate the adaptation to progressive lens designs through a "Satisfaction questionnaire" after 1 week of use of each of the 3 progressive addition lenses. The "Satisfaction questionnaire" assesses: visual comfort, visual acuity at far distances, intermediate, and near distances, and visual fields at far distances, intermediate, and near distances. Each is evaluated on a 5-point scale from 5 (very comfortable) to 1 (very uncomfortable). Entire study duration (approx. 4 weeks)
Secondary Evaluate the preference among progressive lens designs. Evaluate the preference among progressive lens designs through a "Final comparison questionnaire". The survey asks to rank the three pairs of glasses ("The best", "Good", "The worst") with respect to which provides a better distance visual acuity (seeing clear and sharp), wider field of view, and having the least perceived swaying/floating effects. The ranking is conducted for distance, intermediate, and near vision. Entire study duration (approx. 4 weeks)
Secondary Evaluate the fast impression of progressive lens designs. Evaluate first impression of progressive lens designs through a "First impression questionnaire" after 10-15 minutes of wearing each of the 3 PALs. The "First impression questionnaire" scale is (a) very comfortable, (b) comfortable, (c) adequate, (d) slightly uncomfortable, (e) uncomfortable. 10-15 minutes of wearing time.
See also
  Status Clinical Trial Phase
Completed NCT05326607 - Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia N/A
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Completed NCT05495971 - Extended Depth of Focus Contact Lenses for Presbyopia N/A
Completed NCT05464732 - Vivity IOL: Emmetropia Compared to Monovision. N/A
Recruiting NCT06045299 - Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia Phase 3
Active, not recruiting NCT04151550 - Safety & Efficacy of the Laser Scleral Microporation Procedure (Philippines) N/A
Not yet recruiting NCT05506553 - Comparison of Aspheric Toric Intraocular Lenses for Micro-monovision N/A
Completed NCT02554396 - Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia Phase 2
Completed NCT02235831 - DAILIES® AquaComfort Plus® Multifocal (MF) - Comparative Assessment of Visual Performance N/A
Completed NCT02214797 - Dispensing Study to Assess Visual Performance of Prototype Contact Lenses N/A
Enrolling by invitation NCT01443585 - Clinical Evaluation of a Progressive Addition Lens (PAL) N/A
Completed NCT01591499 - Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal N/A
Completed NCT04983589 - A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily Phase 3
Completed NCT02740010 - The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
Recruiting NCT05796453 - Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix N/A
Completed NCT02516306 - A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia Phase 1/Phase 2
Completed NCT05359380 - The Impact of Light Conditions on the Efficacy of Multifocal Intraocular Lens Implantation in Activities of Daily Living
Not yet recruiting NCT04522427 - Study of Presbyopia-correcting Intraocular Lenses in Eyes With Previous Corneal Refractive Surgery N/A
Completed NCT03688425 - Comparison of Clinical Outcomes POD L GF vs POD F GF in Asian Eyes N/A
Recruiting NCT06053463 - Evaluation of Soft Multifocal Lenses in Presbyopic Previous Contact Lens Wearers N/A